| MeSH | C550887 |
| PubChem Compound | 5362449 |
| ChEBI | 146176 |
| CHEMBL | CHEMBL1908323 |
| ZINC | 402848 |
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Drug abuse | FAERS: 13 | US FAERS | |
| 2 | Hypersensitivity | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 3 | Incorrect dose administered | FAERS: 4 | US FAERS | |
| 4 | Overdose | FAERS: 4 | US FAERS | |
| 5 | Dizziness | FAERS: 3 | US FAERS | |
| 6 | Drug Dependence | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 7 | Epistaxis | FAERS: 3 | US FAERS | |
| 8 | Rash erythematous | FAERS: 3 | US FAERS | |
| 9 | Asthenia | FAERS: 2 | US FAERS | |
| 10 | Cerebrovascular accident | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 11 | Choking | FAERS: 2 | US FAERS | |
| 12 | Dependence | FAERS: 2 | US FAERS | |
| 13 | Drug ineffective | FAERS: 2 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 14 | Medication Error | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 15 | Nausea | FAERS: 2 | US FAERS | |
| 16 | Product quality issue | FAERS: 2 | US FAERS | |
| 17 | Product taste abnormal | FAERS: 2 | US FAERS | |
| 18 | Retching | FAERS: 2 | US FAERS | |
| 19 | Sneezing | FAERS: 2 | US FAERS | |
| 20 | Somnolence | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 21 | Thrombosis | FAERS: 2 | US FAERS | |
| 22 | Urticaria | FAERS: 2 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 23 | Vomiting | FAERS: 2 | US FAERS | |
| 24 | Abdominal discomfort | FAERS: 1 | US FAERS | |
| 25 | Accidental overdose | FAERS: 1 | US FAERS | |
| 26 | Aneurysm | FAERS: 1 | US FAERS | |
| 27 | Anxiety | FAERS: 1 | US FAERS | |
| 28 | Apathy | FAERS: 1 | US FAERS | |
| 29 | Aphagia | FAERS: 1 | US FAERS | |
| 30 | Atrial Fibrillation | FAERS: 1 | US FAERS | |
| 31 | Blood glucose decreased | FAERS: 1 | US FAERS | |
| 32 | Chest discomfort | FAERS: 1 | US FAERS | |
| 33 | Circumstance or information capable of leading to medication error | FAERS: 1 | US FAERS | |
| 34 | Cold sweat | FAERS: 1 | US FAERS | |
| 35 | Depressed Level of Consciousness | FAERS: 1 | US FAERS | |
| 36 | Drug administration error | FAERS: 1 | US FAERS | |
| 37 | Drug dispensing error | FAERS: 1 | US FAERS | |
| 38 | Dysgeusia | FAERS: 1 | US FAERS | |
| 39 | Electrocardiogram abnormal | FAERS: 1 | US FAERS | |
| 40 | Embolic stroke | FAERS: 1 | US FAERS | |
| 41 | Emotional distress | FAERS: 1 | US FAERS | |
| 42 | Euphoric mood | FAERS: 1 | US FAERS | |
| 43 | Gastrointestinal Pain | FAERS: 1 | US FAERS | |
| 44 | Intentional drug misuse | FAERS: 1 | US FAERS | |
| 45 | Intentional product misuse | FAERS: 1 | US FAERS | |
| 46 | Laryngitis | FAERS: 1 | US FAERS | |
| 47 | Malaise | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 48 | Morbid thoughts | FAERS: 1 | US FAERS | |
| 49 | Nervousness | FAERS: 1 | US FAERS | |
| 50 | No adverse event | FAERS: 1 | US FAERS | |
| 51 | No reaction on previous exposure to drug | FAERS: 1 | US FAERS | |
| 52 | Product label issue | FAERS: 1 | US FAERS | |
| 53 | Product use issue | FAERS: 1 | US FAERS | |
| 54 | Skin reaction | FAERS: 1 | US FAERS | |
| 55 | Theft | FAERS: 1 | US FAERS | |
| 56 | Therapeutic response unexpected | FAERS: 1 | US FAERS | |
| 57 | Unevaluable event | FAERS: 1 | US FAERS | |
| 58 | Unresponsive to stimuli | FAERS: 1 | US FAERS | |
| 59 | Urinary Incontinence | FAERS: 1 | US FAERS | |
| 60 | Abdominal Pain | Canada Vigilance: 2 | Canada Vigilance | |
| 61 | Ataxia | Canada Vigilance: 1 | Canada Vigilance | |
| 62 | Chills | Canada Vigilance: 2 | Canada Vigilance | |
| 63 | Diplopia | Canada Vigilance: 1 | Canada Vigilance | |
| 64 | Disorientation | Canada Vigilance: 1 | Canada Vigilance | |
| 65 | Erythema | Canada Vigilance: 1 | Canada Vigilance | |
| 66 | Expired product administered | Canada Vigilance: 1 | Canada Vigilance | |
| 67 | Visual Impairment | Canada Vigilance: 1 | Canada Vigilance |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120329
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.